| 1 |
Takeda K, Akira S．Toll-like receptors[J].Curr Protoc Immunol，2015(109):14.
|
| 2 |
O’Neill LA, Golenbock D, Bowie AG.The history of Toll-like receptors - redefining innate immunity[J].Nat Rev Immunol，2013，13(6):453-460.
|
| 3 |
Uno K, Kato K, Shimosegawa T．Novel role of toll-like receptors in Helicobacter pylori-induced gastric malignancy[J].World J Gastroenterol，2014，20(18):5244-5251.
|
| 4 |
Gu J, Sun R, Shen S，et al.The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer[J].Onco Targets Ther，2015(8):2215-2225.
|
| 5 |
Geri G, Vignon P, Aubry A，et al.Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters：a post hoc analysis[J].Intensive Care Med，2019，45(5):657-667.
|
| 6 |
Barton GM, Kagan JC.A cell biological view of Toll-like receptor function: regulation through compartmentalization[J].Nat Rev Immunol，2009，9(8):535-542.
|
| 7 |
Lim KH, Staudt LM.Toll-like receptor signaling[J].Cold Spring Harb Perspect Biol，2013，5(1):a011247.
|
| 8 |
Kogut MH, Iqbal M, He H，et al.Expression and function of Toll-like receptors in chicken heterophils[J].Dev Comp Immunol，2005，29(9):791-807.
|
| 9 |
刘婷婷，王凌霄，杨晓辉，等．MyD88非依赖性信号通路在枸杞多糖抑制糖尿病小鼠肿瘤坏死因子α中的作用[J].浙江大学学报(医学版)，2018，47(1):35-40.
|
| 10 |
Chen JQ, Szodoray P, Zeher M．Toll-Like Receptor Pathways in Autoimmune Diseases[J].Clin Rev Allergy Immunol，2016，50(1):1-17.
|
| 11 |
解鸿翔，周红．信号分子TRIF的研究进展[J].细胞与分子免疫学杂志，2012，28(2):217-220.
|
| 12 |
Prescott HC, Angus DC.Enhancing recovery from sepsis：A review[J].JAMA，2018，319(1):62-75.
|
| 13 |
贺小丽，李德渊，乔莉娜，等．脓毒症流行病学及预后的研究进展[J].中华危重病急救医学，2018，30(5):486-489.
|
| 14 |
Poston JT, Koyner JL.Sepsis associated acute kidney injury[J].BMJ，2019(364):k4891.
|
| 15 |
Veach RA, Liu Y, Zienkiewicz J，et al.Survival，bacterial clearance and thrombocytopenia are improved in polymicrobial Sepsis by targeting nuclear transport shuttles[J].PLoS ONE，2017，12(6):e0179468.
|
| 16 |
朱保月，齐洪娜，张建军，等．早期心肌损伤标志物对老年脓毒症患者病情评估及预后的影响[J].中国老年学杂志，2018，38(19):4708-4711.
|
| 17 |
Flierl MA, Rittirsch D, Huber-Lang MS，et al.Molecular events in the cardiomyopathy of sepsis[J].Mol Med，2008，14(5-6):327-336.
|
| 18 |
Sato R, Nasu M．A review of sepsis-induced cardiomyopathy[J].J Intensive Care，2015，3(1):48.
|
| 19 |
Jentzer JC, Vallabhajosyula S, Khanna AK，et al.Management of refractory vasodilatory shock[J].Chest，2018，154(2):416-426.
|
| 20 |
董瑞安，陈晓迎．脓毒症心肌病研究进展[J].现代医药卫生，2018，34(13):1995-1997.
|
| 21 |
杨霞，李香琴，马晓媛，等．脓毒症血管内皮损伤及调节策略的研究进展[J].中国中西医结合急救杂志，2016，23(1):108-110.
|
| 22 |
师灵灵，韩艳秋，任慧娟，等．脓毒症的病理生理机制研究进展[J].中华医院感染学杂志，2016，26(8):1914-1916.
|
| 23 |
Zhou S, Wang G, Zhang W．Effect of TLR4/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats，via regulation of macrophage activation and inflammatory response[J].Exp Ther Med，2018，15(4):3376-3384.
|
| 24 |
Fallach R, Shainberg A, Avlas O，et al.Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia[J].J Mol Cell Cardiol，2010，48(6):1236-1244.
|
| 25 |
Zhou S, Wang G, Zhang W．Effect of TLR4/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response[J].Exp Ther Med，2018，15(4):3376-3384.
|
| 26 |
白雪，杨冰心，赵婉君，等．艾司洛尔对脓毒症大鼠心肌保护作用及其可能机制[J].青岛大学学报(医学版)，2021，57(1):120-124.
|